|
|
|
Volumn 57, Issue 1, 2008, Pages 66-69
|
|
Steatohepatitis due to antiretroviral therapy
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTIRETROVIRUS AGENT;
ASPARTATE AMINOTRANSFERASE;
EFAVIRENZ;
HYALIN;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
STAVUDINE;
ABDOMINAL DISTENSION;
ADULT;
ANOREXIA;
ARTICLE;
CASE REPORT;
CLINICAL EXAMINATION;
DISEASE DURATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EPIGASTRIC PAIN;
FOLLOW UP;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
JAMAICA;
LIVER BIOPSY;
LIVER FIBROSIS;
LIVER PARENCHYMA;
MALE;
NONALCOHOLIC FATTY LIVER;
PATIENT COMPLIANCE;
PATIENT MONITORING;
PHYSICIAN ATTITUDE;
TREATMENT DURATION;
TREATMENT OUTCOME;
WEIGHT REDUCTION;
ADULT;
ANTI-RETROVIRAL AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
FATTY LIVER;
HEPATITIS, TOXIC;
HIV INFECTIONS;
HUMANS;
MALE;
|
|
EID: 44249099934
PISSN: 00433144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (21)
|
